| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/06/2007 | WO2007139833A2 Imidazoazephinone compounds |
| 12/06/2007 | WO2007139232A1 Insulin sensitivity enhancer |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139128A1 Composition for inhibiting the secretion of creatine phosphokinase |
| 12/06/2007 | WO2007139062A1 Therapeutic agent for obesity, and method for treatment and prevention of obesity |
| 12/06/2007 | WO2007139024A1 Composition for improvement of lipid metabolism |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138933A1 Remedy for diabetes |
| 12/06/2007 | WO2007138905A1 Intestinal eosinophil-suppressing composition |
| 12/06/2007 | WO2007138749A1 Visceral fat accumulation inhibitor, and agent for promoting the increase in and/or inhibiting the decrease in blood adiponectin level |
| 12/06/2007 | WO2007138748A1 Pharmaceutical agent for recovery from fatigue |
| 12/06/2007 | WO2007138322A1 New use for cannabinoid |
| 12/06/2007 | WO2007138311A1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 12/06/2007 | WO2007138304A1 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 12/06/2007 | WO2007137955A1 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | WO2007137833A1 Specifically adapted plant-derived redox catalyst and method for the production thereof |
| 12/06/2007 | WO2007137417A1 Heterocyclic compounds as calcium channel blockers |
| 12/06/2007 | WO2007118873A3 Polymorphs of atorvastatin sodium and magnesium salts |
| 12/06/2007 | WO2007107869A3 Lipid derivatives |
| 12/06/2007 | WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
| 12/06/2007 | WO2007106181A3 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/06/2007 | WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070282003 Compounds for the Treatment of Metabolic Disorders |
| 12/06/2007 | US20070281993 Structured Triglycerides And Emulsions Comprising Same |
| 12/06/2007 | US20070281986 Methods and Compositions for Modulating Satiety |
| 12/06/2007 | US20070281969 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/06/2007 | US20070281954 Cyclohexyl-1,4-diamine compounds |
| 12/06/2007 | US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament |
| 12/06/2007 | US20070281946 Tri(cyclo) substituted amide compounds |
| 12/06/2007 | US20070281941 Dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- alpha ]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; diabetes, obesity, and high blood pressure |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281906 Selective androgen receptor modulators for treating diabetes |
| 12/06/2007 | US20070281042 Combinations of chromium with antidiabetics for glucose metabolism disorders |
| 12/06/2007 | US20070281023 Pharmaceutical composition for modified release insulin sensitiser |
| 12/06/2007 | US20070280925 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 12/06/2007 | US20070280908 Treatment of diabetes with synthetic beta cells |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | DE102006025338A1 Verwendung eines Proteinkonzentrates Use of a protein concentrate |
| 12/06/2007 | DE102006025146A1 Peptide that modulates proteasome activity, e.g. for disease treatment, comprises a human protein sequence |
| 12/06/2007 | DE102006025103A1 Spezifisch adaptierter pflanzlicher Redoxkatalysator, als Mittel zur Behandlung von Stoffwechselveränderungen und immunbiologischen Zellbelastungsschwächen sowie Verfahren zu dessen Herstellung Specifically adapted plant redox catalyst, as agents for the treatment of metabolic changes and immune cell biological stress weaknesses and method for its manufacture |
| 12/06/2007 | CA2653835A1 New use for cannabinoid |
| 12/06/2007 | CA2653805A1 Intestinal eosinophil-suppressing composition |
| 12/06/2007 | CA2653765A1 Visceral fat accumulation inhibitor, and agent for promoting the increase in and/or inhibiting the decrease in blood adiponectin level |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653497A1 Heterocyclic compounds as calcium channel blockers |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2652158A1 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | CA2652044A1 Pyrrolopyrimidine compounds and their uses |
| 12/06/2007 | CA2651710A1 Substituted 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase |
| 12/06/2007 | CA2651663A1 Chemical compounds |
| 12/06/2007 | CA2651373A1 Compounds and methods for modulating fxr |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862455A2 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-undecanoic acid |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1862197A2 Use of a protein concentrate |
| 12/05/2007 | EP1862181A2 Combination therapy using an 11B-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
| 12/05/2007 | EP1862173A1 Promoter of regeneration of pancreatic cell, and promoter of insulin production in pancreatic cell |
| 12/05/2007 | EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/05/2007 | EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 12/05/2007 | EP1861382A1 Fused aromatic compounds having anti-diabetic activity |
| 12/05/2007 | EP1861113A2 Use of an onion extract for making a composition to control weight gain |
| 12/05/2007 | EP1861091A1 Compounds having lipid lowering properties |
| 12/05/2007 | EP1861087A2 Treatment with statin and omega-3 fatty acids and a combination product thereof |
| 12/05/2007 | EP1658288B1 2-amino-5-benzoylthiazole npy antagonists |
| 12/05/2007 | EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1305399B1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 12/05/2007 | EP1268397B1 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 12/05/2007 | EP1148872B1 Stable pharmaceutical formulation comprising pravastatin or atorvastatin |
| 12/05/2007 | CN200984282Y Argon-arc welding synchronized self-controlled eyes-protecing tool |
| 12/05/2007 | CN101084206A N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 12/05/2007 | CN101084205A N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 12/05/2007 | CN101084203A New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 12/05/2007 | CN101084193A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 12/05/2007 | CN101084009A Gh secretagogues and uses thereof |
| 12/05/2007 | CN101083994A Heterocyclic derivatives and their use as therapeutic agents |
| 12/05/2007 | CN101083993A Heterocyclic derivatives and their use as therapeutic agents |
| 12/05/2007 | CN101083992A Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 12/05/2007 | CN101083986A Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (scd) |
| 12/05/2007 | CN101083982A Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 12/05/2007 | CN101081280A Capsule for lowering blood sugar and preventing thirst |
| 12/05/2007 | CN101081244A Method for the preservation of biological activity of activity polypeptides agent which is made from plants and is took orally for reducing blood suger |
| 12/05/2007 | CN101081242A Notoginseng extract for treating cardiovascular disease and method for making same |
| 12/05/2007 | CN101081241A Application of pine nut oil in the preparing of slimming medicine |
| 12/05/2007 | CN101081222A Novel medicine use of indirubin derivates |
| 12/05/2007 | CN101081218A Rapid-disintegrated oral film and method for making same |
| 12/05/2007 | CN101081214A Methodc for preparing sub-micron gemfibrozil medicament powder |
| 12/05/2007 | CN101081073A Selenium germanium peptide jujube tea paste for effecting radical cure of hepatitis B |
| 12/05/2007 | CN101081072A Selenium germanium peptide jujube tea paste for effecting radical cure of sugar diabetes |
| 12/05/2007 | CN101081054A Amber aroma health-care tea |
| 12/05/2007 | CN101081052A Method for making edible 'MilpaAita Cacti' tea |